Medeon Biodesign, Inc. logo

Medeon Biodesign, Inc. (6499)

Market Closed
11 Aug, 05:30
TWSE TWSE
NT$
62. 00
+2
+3.3333%
NT$
3.92B Market Cap
- P/E Ratio
- Div Yield
216,442 Volume
- Eps
NT$ 60
Previous Close
Add Transaction
Day Range
59 62
Year Range
55.8 134
Want to track 6499 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

6499 closed today higher at NT$62, an increase of 3.3333% from yesterday's close, completing a monthly decrease of -13.0435% or -NT$9.3. Over the past 12 months, 6499 stock lost -34.0426%.
6499 is not paying dividends to its shareholders.
The last earnings report, released on Apr 30, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.9704%, based on the last three reports.
Medeon Biodesign, Inc. has completed 5 stock splits, with the recent split occurring on Aug 23, 2023.
The company's stock is traded on one exchange.

6499 Chart

People also search for

Favite Inc.
NT$ 89
-1.3304%
BenQ Materials Corp.
NT$ 24.8
-2.9354%
Kaimei Electronic Corp.
NT$ 128.5
+3.629%
PLANET Technology Corporation
NT$ 159.5
-0.9317%
Aces Electronic Co., Ltd.
NT$ 111
+1.8349%

Medeon Biodesign, Inc. (6499) FAQ

What is the stock price today?

The current price is NT$62.00.

On which exchange is it traded?

Medeon Biodesign, Inc. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 6499.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 3.92B.

Has Medeon Biodesign, Inc. ever had a stock split?

Medeon Biodesign, Inc. had 5 splits and the recent split was on Aug 23, 2023.

Medeon Biodesign, Inc. Profile

Electronic Equipment, Instruments & Components Industry
Information Technology Sector
Dr. Yue-Teh Jang Ph.D. CEO
TWSE Exchange
TW0006499007 ISIN
Taiwan Country
- Employees
- Last Dividend
23 Aug 2023 Last Split
- IPO Date

Overview

Medeon Biodesign, Inc. is a Taiwan-based company established in 2012 with operations extending to the United States. The company is deeply embedded in the medical devices sector, engaging in comprehensive activities encompassing research and development, manufacturing, and commercialization of its products. Medeon Biodesign is dedicated to innovating in the field of minimally invasive surgery equipment, alongside providing contract manufacturing services and participating in equity investments related to medical devices. Their commitment lies in advancing medical technologies to enhance surgical procedures and patient outcomes, positioning them as forefront players in the medical devices landscape.

Products and Services

  • Duett: A vascular graft system designed to facilitate the process of connecting blood vessels, hence improving the outcomes of surgeries requiring vascular reconstruction.
  • ClickClean: A novel solution that ensures clear visibility for surgeons during laparoscopic surgeries by effectively cleaning the laparoscope lens without removing it from the patient.
  • AbClose: A device aimed at preventing port site herniation, which can occur due to improper closure after laparoscopic surgeries, thereby enhancing postoperative recovery.
  • UroCross: An expander system specifically designed to aid in urological surgeries, improving the safety and efficiency of procedures within the urinary tract.
  • PUMA: A dedicated solution for treating orthopedic extremity injuries, focusing on minimally invasive approaches that promise quicker recovery times and reduced surgical impact.
  • Cross-Seal: A large-bore closure device that provides a secure and reliable method for closing large puncture sites, commonly required after complex vascular procedures.
  • Contract Manufacturing: Medeon Biodesign extends its expertise into contract manufacturing, offering other companies within the sector the ability to have their medical devices produced with high-quality standards and efficiency.
  • Equity Investment and Commerce of Medical Devices: Beyond its manufacturing and development roles, Medeon Biodesign engages in strategic equity investments and the commercial activities of medical devices, contributing to the growth and innovation of the medical devices industry.
  • Manufacturing and Sale of Injection Molding and Components: The company also specializes in the manufacturing and sale of injection molding and components crucial for medical devices, showcasing their versatility and comprehensive capabilities within the medical device manufacturing sphere.

Contact Information

Address: 116, HouGang Street
Phone: 886 2 2881 6686